Top Gainers and Losers on September 02, 2025: Tata Consumer Lead Gainers and Dr. Reddy’s Drag Markets Lower

On Tuesday, September 2, 2025, Indian markets gave up early gains and closed lower as banking and pharma stocks dragged indices down ahead of the two-day GST Council meeting starting tomorrow.

The Sensex fell 752 points from the day’s high of 80,761.14 to touch 80,008.50, finally closing 206.61 points (0.26%) lower at 80,157.88. Similarly, the Nifty slipped 234 points from its high of 24,756.10 to 24,522.35, before ending 45.45 points (0.18%) down at 24,579.60.

Top Gainers of the Day

• Tata Consumer Products (TATACONSUM) surged 2.77%, closing at ₹1,105.50 with a volume of 16.5 lakh shares.
• Nestle India (NESTLEIND) gained 2.22%, hitting ₹1,200.50 with over 17.7 lakh shares traded.
• Power Grid (POWERGRID) rose 2.20%, ending at ₹286.00, backed by a strong 1.7 crore shares volume.
• NTPC advanced 1.80% to ₹336.65, with 92.2 lakh shares changing hands.
• Tata Steel (TATASTEEL) moved up 1.46%, closing at ₹158.45 on a volume of 2.12 crore shares.

Top Losers of the Day

• Dr. Reddy’s (DRREDDY) slipped 2.34% to ₹1,250.00 with 16.3 lakh shares traded.
• Mahindra & Mahindra (M&M) dropped 2.33%, closing at ₹3,238.00 on a heavy volume of 30.7 lakh shares.
• ICICI Bank (ICICIBANK) declined 1.42%, ending at ₹1,391.00, with a massive 71.6 lakh shares traded.
• Asian Paints (ASIANPAINT) fell 1.25% to ₹2,538.00 with a turnover of ₹26,105.73 lakh.
• Cipla (CIPLA) eased 1.21%, finishing at ₹1,568.00 on a volume of 11.6 lakh shares.

Read More: Upcoming Dividends in September 2025: NTPC, ONGC, Patanjali Foods, and More.

Conclusion

Markets ended lower as banking and pharma stocks dragged indices ahead of the GST Council meeting. While FMCG and power stocks showed strength, pressure from banks and pharma capped overall gains, keeping investor sentiment cautious.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.